A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With Hypertension.

AstraZeneca1 site in 1 country2,000 target enrollmentApril 2008

ConditionsHypertension

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypertension
Sponsor: AstraZeneca
Enrollment: 2000
Locations: 1
Primary Endpoint: Attainment rate to the target blood pressure.
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of hypertension patients having Type 2 Diabetes mellitus, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Registry

clinicaltrials.gov

Start Date

April 2008

End Date

October 2008

Last Updated

15 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

AstraZeneca

Eligibility Criteria

Inclusion Criteria

•Outpatient Type II DM patients receiving hypertension medication in 2006
•Patient with Type II DM receiving hypertension medication during at least 1 year.

Exclusion Criteria

•Secondary hypertension patients
•Patients not receiving hypertension medication

Outcomes

Primary Outcomes

Attainment rate to the target blood pressure.

Time Frame: After collecting all Patient Record Form.

Secondary Outcomes

Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease.(After collecting all Patient Record Form.)
Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases.(After collecting all Patient Record Form.)